U.S. Markets closed

InspireMD, Inc. (NSPR)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.6124-0.0221 (-3.48%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6345
Bid0.6040 x 800
Ask0.6100 x 800
Day's Range0.6004 - 0.6249
52 Week Range0.2800 - 1.4800
Avg. Volume18,524,270
Market Cap72.16M
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Preview: InspireMD's Earnings

    On Tuesday, March 09, InspireMD (AMEX:NSPR) will release its latest earnings report. Benzinga's outlook for InspireMD is included in the following report. Net Income, Earnings, And Earnings Per Share Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding. Earnings And Revenue InspireMD EPS will likely be near $0.06 while revenue will be around $1.10 million, according to analysts. In the same quarter last year, InspireMD announced EPS of $0.57 on revenue of $1.01 million. What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter? Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin. View more earnings on NSPR If the company were to post earnings in line with the consensus estimate when it reports Tuesday, EPS would be up 89.47%. Revenue would be up 8.59% from the same quarter last year. InspireMD's reported EPS has stacked up against analyst estimates in the past like this: Quarter Q2 2020 Q1 2020 Q4 2020 EPS Estimate -0.35 -0.63 -0.57 EPS Actual -0.20 -0.43 -0.57 Revenue Estimate 200.00 K 1.00 M 1.60 M Revenue Actual 313.00 K 1.03 M 1.01 M Stock Performance Shares of InspireMD were trading at $0.744 as of March 05. Over the last 52-week period, shares are up 18.67%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release. Do not be surprised to see the stock move on comments made during its conference call. InspireMD is scheduled to hold the call at 08:30:00 ET and can be accessed here. See more from BenzingaClick here for options trades from BenzingaA Preview Of Barnes & Noble Education's EarningsEarnings Outlook for Vertex Energy© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Is InspireMD Inc (NSPR) A Good Buy Now?
    Insider Monkey

    Is InspireMD Inc (NSPR) A Good Buy Now?

    Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]

  • InspireMD, Inc. (NYSEMKT:NSPR) Just Reported, And Analysts Assigned A US$0.85 Price Target
    Simply Wall St.

    InspireMD, Inc. (NYSEMKT:NSPR) Just Reported, And Analysts Assigned A US$0.85 Price Target

    InspireMD, Inc. (NYSEMKT:NSPR) defied analyst predictions to release its third-quarter results, which were ahead of...